Cyclerion Therapeutics Inc (CYCN) Directors and Executive Officers

Officers & Directors

Errol De Souza - Director

Rhonda Chicko - Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Steven Hyman - Director

Regina Graul - President (Principal Executive Officer)

Michael Higgins - Director

Terrance McGuire - Director

Peter Hecht - Director

Dina Katabi - Director,

News about Cyclerion Therapeutics Inc Key Personnel

Cyclerion Therapeutics: Strategic Shifts and Leadership Overhaul Aim to Revitalize Growth Amid Financial Challenges,

Cyclerion Therapeutics: Navigating Growth Amidst ChallengesIn a proactive move aimed at invigorating growth and repositioning itself in the competitive pharmaceutical landscape, Cyclerion Therapeutics Inc. has recently emphasized leveraging its legacy soluble guanylate cyclase (sGC) stimulator portfolio to generate immediate revenues. This strategic initiative comes on the heels of their latest financial disclosures, which illustrate an interesting juxtaposition: the company secured a return on assets (ROA) of 6.81% in the third quarter of 2024—a significant improvement over its historical average ROA of -61.9%. Despite this improvement, the company s ROA fell compared to the previous quarter, which raise...

Cyclerion Therapeutics Appoints Dr. Regina Graul as President to Lead Rebuilding Efforts

Cyclerion Therapeutics Inc, a leading pharmaceutical company, has recently ann...